MedPath

Gender differences in the relationship between TG/HDL-C ratio and metabolic syndrome

Not Applicable
Conditions
Metabolic syndrome
Registration Number
JPRN-UMIN000049445
Lead Sponsor
ihon University Hospital, Health Planning Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10000
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria included refusal to provide consent for participation in the study, current lipid-modified, treatment, and diagnosis of cerebral and/or cardiovascular disease, serum triglyceride levels more than 400mg/dL, and no measurement of abdominal circumference and serum lipid level.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary efficacy parameter was the relationship between the TG/HDL-C ratio and abdominal obesity by gender.
Secondary Outcome Measures
NameTimeMethod
The secondary endpoint was the relationship between the TG/HDL-C ratio and the prevalence of Mets and its components as cardio-metabolic risk by gender.
© Copyright 2025. All Rights Reserved by MedPath